Biotech Analyst Outlines COVID-19 Vaccine Progress
1/12/2021
Steve Seedhouse, Raymond James biotechnology analyst, discusses the Moderna and Pfizer vaccines’ trial results, manufacturing plans and rollout strategies.
Lifestyle & Technology
10-Year Expected to Creep Higher to 1.5% by Year-End
1/12/2021
Doug Drabik and Nick Goetze, Raymond James fixed income managing directors, expect a slight steepening of the yield curve over the course of 2021.
Markets & Investing
This Should Be a Bright – If Bumpy – Year for Stocks
1/11/2021
While 2021 will likely be a positive year for equities, the longer-term outlook is clouded by the potential for higher taxes, higher interest rates and lower valuations.
Markets & Investing
Expect Policy Change for Taxes, Climate, Consumer Protection
1/11/2021
Washington Policy Analyst Ed Mills discusses the policy and market implications of the U.S. election results.
Economy & Policy
10 Themes That Will Affect Your 2021 Investing
1/11/2021
What can investors expect this year? Positive (but unsteady) economic growth, a powerful boost in earnings and continued success for information technology stocks, says CIO Larry Adam.
Markets & Investing
Laying the Groundwork for Tax Season
1/7/2021
Smart moves at the beginning of tax season can help get your financial house in order.
Tax Planning
Market and Policy Impact of Georgia Election Results
1/6/2021
Washington Policy Analyst Ed Mills and Healthcare Policy Analyst Chris Meekins discuss the implications of the Georgia Senate election results.
Economy & Policy